Grace Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Grace Lim has a total of 228 co-authors. Here are the top co-authors by number of shared publications:
Kelsea R. LaSorda
Department of Anesthesiology & Perioperative Medicine, University of Pittsburgh School of Medicine
8 shared publicationsLia M. Farrell
Department of Anesthesiology & Perioperative Medicine, University of Pittsburgh School of Medicine
6 shared publicationsBrendan Carvalho
Department of Anesthesiology, Perioperative & Pain Medicine, Stanford University, Palo Alto, CA
4 shared publicationsC. Tyler Smith
4 shared publicationsJonathan H. Waters
Department of Anesthesiology, Magee-Women's Hospital of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States of America
4 shared publicationsRuth Landau
Department of Anesthesiology & Perioperative Medicine, Columbia University, New York, NY
4 shared publications
Latest Publications
- Open Access
- 21 July 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 143 (4) , 732-740
Elevating Anesthesia Choices for Cesarean Delivery: A Roadmap for Patient-Centered Research and Solutions With Key Findings and Recommendations From the ELEVATE Project
Was not provided for this article.
- 21 July 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 143 (4) , 732-740
Open AccessElevating Anesthesia Choices for Cesarean Delivery: A Roadmap for Patient-Centered Research and Solutions With Key Findings and Recommendations From the ELEVATE Project
Was not provided for this article.
- 10 March 2026
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 144 (4) , 752-755
Maternal Cardiac Arrest: Big Data, Rare Events, and Moving from Incidence to Insight
- 10 March 2026
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 144 (4) , 752-755
Maternal Cardiac Arrest: Big Data, Rare Events, and Moving from Incidence to Insight
- Open Access
- 2 February 2026
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 10 (2)
Physiologic clot strength by thromboelastography at extremely low and normal platelet counts in thrombocytopenic pregnant patients
- 2 February 2026
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 10 (2)
Open AccessPhysiologic clot strength by thromboelastography at extremely low and normal platelet counts in thrombocytopenic pregnant patients
- 11 November 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 143 (6) , 1449-1452
Placental Transfer of Tranexamic Acid and the Case for Earlier Use in Obstetric Hemorrhage Trials
The current practice of delaying tranexamic acid administration until after cord clamping may blunt its therapeutic potential in obstetric hemorrhage. Although this precaution aims to avoid fetal exposure, pharmacokinetic and available safety data suggest that such exposure poses minimal fetal risk. Data from limited cesarean and placenta previa studies indicate that earlier administration—before surgical incision or onset of bleeding—may reduce blood loss without harming neonates. Given that tranexamic acid is most effective when given early or before the onset of fibrinolysis, obstetric clinical trials and future protocols should reconsider the current default to post–cord clamping dosing. Earlier, targeted tranexamic acid administration may improve maternal outcomes without compromising neonatal safety and should be considered part of a rational approach in obstetric hemorrhage clinical trials.
- 11 November 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 143 (6) , 1449-1452
Placental Transfer of Tranexamic Acid and the Case for Earlier Use in Obstetric Hemorrhage Trials
The current practice of delaying tranexamic acid administration until after cord clamping may blunt its therapeutic potential in obstetric hemorrhage. Although this precaution aims to avoid fetal exposure, pharmacokinetic and available safety data suggest that such exposure poses minimal fetal risk. Data from limited cesarean and placenta previa studies indicate that earlier administration—before surgical incision or onset of bleeding—may reduce blood loss without harming neonates. Given that tranexamic acid is most effective when given early or before the onset of fibrinolysis, obstetric clinical trials and future protocols should reconsider the current default to post–cord clamping dosing. Earlier, targeted tranexamic acid administration may improve maternal outcomes without compromising neonatal safety and should be considered part of a rational approach in obstetric hemorrhage clinical trials.
- 7 November 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 144 (1) , 237-239
Variability in Use of Intravenous Adjuncts for Cesarean Delivery under Neuraxial Anesthesia
- 7 November 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 144 (1) , 237-239
Variability in Use of Intravenous Adjuncts for Cesarean Delivery under Neuraxial Anesthesia
- 29 August 2025
- Published by Elsevier in International Journal of Obstetric Anesthesia
- Vol. 64, 104760
A comparative study of patient and provider priorities for cesarean delivery anesthesia care
- 29 August 2025
- Published by Elsevier in International Journal of Obstetric Anesthesia
- Vol. 64, 104760
A comparative study of patient and provider priorities for cesarean delivery anesthesia care
- Open Access
- 16 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5037
Feasibility of Hypotension Prediction Index-Guided Monitoring for Epidural Labor Analgesia: A Randomized Controlled Trial
Background: Hypotension following epidural labor analgesia (ELA) is its most common complication, affecting approximately 20% of patients and posing risks to both maternal and fetal health. As digital tools and predictive analytics increasingly shape perioperative and obstetric anesthesia practices, real-world implementation data are needed to guide their integration into clinical care. Current monitoring practices rely on intermittent non-invasive blood pressure (NIBP) measurements, which may delay recognition and treatment of hypotension. The Hypotension Prediction Index (HPI) algorithm uses continuous arterial waveform monitoring to predict hypotension for potentially earlier intervention. This clinical trial evaluated the feasibility, acceptability, and efficacy of continuous HPI-guided treatment in reducing time-to-treatment for ELA-associated hypotension and improving maternal hemodynamics. Methods: This was a prospective randomized controlled trial design involving healthy pregnant individuals receiving ELA. Participants were randomized into two groups: Group CM (conventional monitoring with NIBP) and Group HPI (continuous noninvasive blood pressure monitoring). In Group HPI, hypotension treatment was guided by HPI output; in Group CM, treatment was based on NIBP readings. Feasibility, appropriateness, and acceptability outcomes were assessed among subjects and their bedside nurse using the Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM) instruments. The primary efficacy outcome was time-to-treatment of hypotension, defined as the duration between onset of hypotension and administration of a vasopressor or fluid therapy. This outcome was chosen to evaluate the clinical responsiveness enabled by HPI monitoring. Hypotension is defined as a mean arterial pressure (MAP) < 65 mmHg for more than 1 min in Group CM and an HPI threshold < 75 for more than 1 min in Group HPI. Secondary outcomes included total time in hypotension, vasopressor doses, and hemodynamic parameters. Results: There were 30 patients (Group HPI, n = 16; Group CM, n = 14) included in the final analysis. Subjects and clinicians alike rated the acceptability, appropriateness, and feasibility of the continuous monitoring device highly, with median scores ≥ 4 across all domains, indicating favorable perceptions of the intervention. The cumulative probability of time-to-treatment of hypotension was lower by 75 min after ELA initiation in Group HPI (65%) than Group CM (71%), although this difference was not statistically significant (log-rank p = 0.66). Mixed models indicated trends that Group HPI had higher cardiac output (β = 0.58, 95% confidence interval −0.18 to 1.34, p = 0.13) and lower systemic vascular resistance (β = −97.22, 95% confidence interval −200.84 to 6.40, p = 0.07) throughout the monitoring period. No differences were found in total vasopressor use or intravenous fluid administration. Conclusions: Continuous monitoring and precision hypotension treatment is feasible, appropriate, and acceptable to both patients and clinicians in a labor and delivery setting. These hypothesis-generating results support that HPI-guided treatment may be associated with hemodynamic trends that warrant further investigation to determine definitive efficacy in labor analgesia contexts.
- 16 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5037
Open AccessFeasibility of Hypotension Prediction Index-Guided Monitoring for Epidural Labor Analgesia: A Randomized Controlled Trial
Background: Hypotension following epidural labor analgesia (ELA) is its most common complication, affecting approximately 20% of patients and posing risks to both maternal and fetal health. As digital tools and predictive analytics increasingly shape perioperative and obstetric anesthesia practices, real-world implementation data are needed to guide their integration into clinical care. Current monitoring practices rely on intermittent non-invasive blood pressure (NIBP) measurements, which may delay recognition and treatment of hypotension. The Hypotension Prediction Index (HPI) algorithm uses continuous arterial waveform monitoring to predict hypotension for potentially earlier intervention. This clinical trial evaluated the feasibility, acceptability, and efficacy of continuous HPI-guided treatment in reducing time-to-treatment for ELA-associated hypotension and improving maternal hemodynamics. Methods: This was a prospective randomized controlled trial design involving healthy pregnant individuals receiving ELA. Participants were randomized into two groups: Group CM (conventional monitoring with NIBP) and Group HPI (continuous noninvasive blood pressure monitoring). In Group HPI, hypotension treatment was guided by HPI output; in Group CM, treatment was based on NIBP readings. Feasibility, appropriateness, and acceptability outcomes were assessed among subjects and their bedside nurse using the Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM) instruments. The primary efficacy outcome was time-to-treatment of hypotension, defined as the duration between onset of hypotension and administration of a vasopressor or fluid therapy. This outcome was chosen to evaluate the clinical responsiveness enabled by HPI monitoring. Hypotension is defined as a mean arterial pressure (MAP) < 65 mmHg for more than 1 min in Group CM and an HPI threshold < 75 for more than 1 min in Group HPI. Secondary outcomes included total time in hypotension, vasopressor doses, and hemodynamic parameters. Results: There were 30 patients (Group HPI, n = 16; Group CM, n = 14) included in the final analysis. Subjects and clinicians alike rated the acceptability, appropriateness, and feasibility of the continuous monitoring device highly, with median scores ≥ 4 across all domains, indicating favorable perceptions of the intervention. The cumulative probability of time-to-treatment of hypotension was lower by 75 min after ELA initiation in Group HPI (65%) than Group CM (71%), although this difference was not statistically significant (log-rank p = 0.66). Mixed models indicated trends that Group HPI had higher cardiac output (β = 0.58, 95% confidence interval −0.18 to 1.34, p = 0.13) and lower systemic vascular resistance (β = −97.22, 95% confidence interval −200.84 to 6.40, p = 0.07) throughout the monitoring period. No differences were found in total vasopressor use or intravenous fluid administration. Conclusions: Continuous monitoring and precision hypotension treatment is feasible, appropriate, and acceptable to both patients and clinicians in a labor and delivery setting. These hypothesis-generating results support that HPI-guided treatment may be associated with hemodynamic trends that warrant further investigation to determine definitive efficacy in labor analgesia contexts.
- 8 July 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 143 (2) , 255-257
Obstetric Anesthesia at a Crossroads: Reflections on a 40-year Workforce Survey
- 8 July 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 143 (2) , 255-257
Obstetric Anesthesia at a Crossroads: Reflections on a 40-year Workforce Survey
- Open Access
- 2 July 2025
- Published by Taylor & Francis in Journal of Psychosomatic Obstetrics & Gynecology
- Vol. 46 (1) , 2527670
Psychophysical correlates of labor pain intensity and unpleasantness
The neurobiological mechanisms linking perinatal pain and mood disorders remain unclear. Emotional dimensions of labor pain, particularly unpleasantness, may reflect engagement of limbic pathways shared with affective disorders. This study examined whether prenatal quantitative sensory testing (QST) parameters are associated with the sensory and emotional dimensions of labor pain. Healthy primiparous women were enrolled and followed from third trimester through delivery. Prenatal QST assessed mechanical and thermal thresholds, tolerances, and temporal summation. Labor pain was recorded hourly using a validated electronic diary. Univariable linear regression evaluated relationships between QST measures and labor pain outcomes. Of 164 participants completing QST, , 55 had complete labor pain diaries. Prenatal QST parameters were associated with emotional, but not sensory, aspects of labor pain. Pain unpleasantness was associated with average heat threshold (Coefficient = 40.3, SE = 17.2, p = 0.02), post wind-up pain (Coefficient = -48.9, SE = 25.3, p = 0.06) and post probe pain (Coefficient = -52.7, SE = 26.8, p = 0.06), using a p < 0.1 threshold to identify associations. Although exploratory, these findings suggest that prenatal QST, particularly thermal threshold and central sensitization measures, may help identify individuals at risk for maladaptive labor pain and postpartum mood disorders.
- 2 July 2025
- Published by Taylor & Francis in Journal of Psychosomatic Obstetrics & Gynecology
- Vol. 46 (1) , 2527670
Open AccessPsychophysical correlates of labor pain intensity and unpleasantness
The neurobiological mechanisms linking perinatal pain and mood disorders remain unclear. Emotional dimensions of labor pain, particularly unpleasantness, may reflect engagement of limbic pathways shared with affective disorders. This study examined whether prenatal quantitative sensory testing (QST) parameters are associated with the sensory and emotional dimensions of labor pain. Healthy primiparous women were enrolled and followed from third trimester through delivery. Prenatal QST assessed mechanical and thermal thresholds, tolerances, and temporal summation. Labor pain was recorded hourly using a validated electronic diary. Univariable linear regression evaluated relationships between QST measures and labor pain outcomes. Of 164 participants completing QST, , 55 had complete labor pain diaries. Prenatal QST parameters were associated with emotional, but not sensory, aspects of labor pain. Pain unpleasantness was associated with average heat threshold (Coefficient = 40.3, SE = 17.2, p = 0.02), post wind-up pain (Coefficient = -48.9, SE = 25.3, p = 0.06) and post probe pain (Coefficient = -52.7, SE = 26.8, p = 0.06), using a p < 0.1 threshold to identify associations. Although exploratory, these findings suggest that prenatal QST, particularly thermal threshold and central sensitization measures, may help identify individuals at risk for maladaptive labor pain and postpartum mood disorders.
- 13 May 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 142 (6) , 992-994
Opioids, Expectations, and Ethos: A Global Take on Pain Management in Surgery and Pregnancy
- 13 May 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 142 (6) , 992-994
Opioids, Expectations, and Ethos: A Global Take on Pain Management in Surgery and Pregnancy